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Necrotizing Enterocolitis following Gastroschisis Repair: An Update
Abstract
Purpose:
Necrotizing enterocolitis (NEC) is a known complication of gastroschisis with an incidence above the
expected rate in the neonatal population. While many physicians today are aware of this association, the
last publication to explore this association in detail and identify possible risk factors of NEC in
gastroschisis patients was published over twenty years ago. From our large database of patients with
gastroschisis managed by a single group of pediatric surgeons, we reviewed our experience and the
recent literature to update what is known about gastroschisis and NEC.
Methods:
From 2001 to 2017, a gastroschisis registry was maintained. Data from 218 gastroschisis patients were
reviewed. Patient demographics and hospital course were reviewed. Patients with confirmed NEC were
compared to those without NEC.
Results
Results:
Two hundred eighteen patients were born with gastroschisis during the time frame of this study. We
observed a 5% rate (11 of 218) of NEC. Five patients (45%) developed recurring NEC and 4 patients (36%)
were readmitted for NEC development following initial discharge. Variables associated with NEC included
low gestational age (P=0.016) and low birth weight (P=0.003). Patients born prior to 37 weeks gestation
had a 4.8 times greater risk of developing NEC than those born at term. Rates of IUGR were not
statistically different between NEC and non-NEC patients. The method of delivery (cesarean vs vaginal),
use of a silo, and form of nutrition were not significantly associated with NEC development.
Conclusions
Conclusions:
The overall incidence of NEC has decreased compared to earlier reports. NEC does complicate the
hospital course for patients, significantly increasing duration of in-hospital treatment. NEC in
gastroschisis differs in comparison to traditional NEC, presenting later in life. Risk factors identified
include low gestational age and low birth weight. Avoiding elective preterm deliveries may decrease the
rate of NEC in gastroschisis.
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Abstract
Introduction: Necrotizing enterocolitis
(NEC) is a known complication of
gastroschisis with an incidence above the
expected rate in the neonatal population.
While many physicians today are aware
of this association, the last publication to
explore this association in detail and identify
possible risk factors of NEC in gastroschisis
patients was published over twenty years
ago. From our large database of patients
with gastroschisis, managed by a single
group of pediatric surgeons, we reviewed our
experience and the recent literature to update
what is known about gastroschisis and NEC.
Methods: From 2001 to 2017, a gastroschisis
registry was maintained. Data from 218
gastroschisis patients were reviewed. Patient
demographics and hospital course were
reviewed. Patients with confirmed NEC were
compared to those without NEC.
Results: Two hundred eighteen patients were
born with gastroschisis during the time frame
of this study. We observed a 5% rate (11 of
218) of NEC. Five patients (45%) developed
recurring NEC and 4 patients (36%) were
readmitted for NEC development following
initial discharge. Variables associated with
NEC included low gestational age (P=0.016)
and low birth weight (P=0.003). Patients born
prior to 37 weeks gestation had a 4.8 times
greater risk of developing NEC than those
born at term. Rates of intrauterine growth
restriction (IUGR) were not statistically
different between NEC and non-NEC
patients. The method of delivery (cesarean vs
vaginal), use of a silo, and form of nutrition
were not significantly associated with NEC
development.
Conclusions: The overall incidence of NEC,
based on our data, has decreased compared
to earlier reports. NEC does complicate the
hospital course for patients, significantly
increasing duration of in-hospital treatment.
NEC in gastroschisis differs in comparison to
traditional NEC, presenting later in life. Risk
factors identified include low gestational age
and low birth weight. Avoiding elective preterm deliveries may decrease the rate of NEC
in gastroschisis.
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Introduction

Materials and Methods

Gastroschisis is a congenital right-sided
paraumbilical defect allowing protrusion
of intestines and other abdominal viscera
out of the abdominal cavity, occurring in
approximately 1 in 4000 live births1 and has
increased by about 6% every two years for
reasons unknown.2 Necrotizing enterocolitis
(NEC) is a bacterial infection of the intestine,
primarily observed in pre-term and small
for gestational age (SGA) babies.3 The
reported rate of necrotizing enterocolitis in
gastroschisis patients has been quite variable
in previous studies.4-16 While many physicians
today are aware of the association of NEC in
gastroschisis patients, the last publication to
explore this association in detail and identify
possible risk factors of NEC in gastroschisis
patients was published over twenty years
ago.4 We examined our experience with
gastroschisis to identify risk factors for
necrotizing enterocolitis in this patient
population.

Patient Population and Data Collection:
From 2001 to 2017, a gastroschisis registry
was prospectively maintained at Children’s
Hospital and Medical Center, the University
of Nebraska Medical Center, and Creighton
University Medical Center (Omaha, NE).
Patient demographics, surgical details,
postoperative infections and complications,
and length of stay were reviewed. Patients
with confirmed NEC were compared to those
without NEC. This study was approved by the
University of Nebraska Medical Center- Joint
Pediatric Institutional Review Board (#44509-EP).
Definitions: The diagnosis of necrotizing
enterocolitis was made using Bell’s
classification of radiographic and clinical
findings (Table 1). Clinical findings of NEC
included abdominal distention, hematochezia,
and hemodynamic instability. Radiographic
findings included pneumatosis intestinalis and
portal venous gas. Prematurity was defined
as a gestational age less than 37 weeks.
Intrauterine growth restriction (IUGR) was
defined as a birth weight at or below the 10th
percentile for gestational age.

Table 1.

Modified Bell’s Criteria were utilized to assist with staging NEC in our study.
Stage

Systemic signs

Abdominal signs

Radiographic signs

Treatment

IA
Suspected

Temp instability
Apnea
Bradycardia
Lethargy

Gastric retention
Abd distention
Emesis
Heme + stool

Mild ileus
Intestinal dilation

NPO
Abx x3 days

IB
Suspected

Same as IA

Grossly bloody stool

Same as IA

Same as IA

IIA

Same as IA

Same as IB +
Absent bowel sounds
± abdominal
tenderness

Intestinal dilation
Ileus
Pneumatosis
intestinalis

NPO
Abx x 7-10 days

IIB

Same as IA +
Metabolic acidosis
Thrombocytopenia

Same as IIA +
Abdominal
tenderness
± abdominal cellulitis
or RLQ mass

Same as IIA + ascites

NPO
Abx x 14 days

IIIA
Intact bowel

Same as IIB +
Hypotension
Bradycardia
Severe apnea
DIC
neutropenia

Same as IIB _
Peritonitis
Abdominal distention

Same as IIB

NPO
Abx x 14 days
Fluid resuscitation
Inotropic support
Ventilator therapy
Paracentesis

IIIB
Perforated
bowel

Same as IIIA

Same as IIIA

Same as IIIA +
Pneumoperitoneum

Same as IIIa +
Surgery
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Statistical Analysis: Results were expressed
as mean±SD or median and interquartile
range as appropriate. Relative risks were also
assessed. Analysis was performed using the
Mann-Whitney test for continuous data and
the Fisher’s exact test for categorical data.
A p-value of less than 0.05 was considered
statistically significant.

Results
Two hundred eighteen patients were born
with gastroschisis during the time frame of
this study. The average gestational age was
35.7 weeks with the average birth weight of
2455 grams. One hundred forty-six (67%)
were born via cesarean section. Thirty-three
percent (71 of 218) of patients were carried
to term with the remaining patients delivered
prior to 37 weeks gestation. Patients were kept
on the ventilator for an average of 5.6 days
(median=2). Silos were used on 45% (98 of
218) of patients for an average of 7.2 days.
The average length of stay was 55.2 days
(median=36.5) (Table 2).
We observed a 5% rate (11 of 218) of
NEC. Five patients (45% of NEC patients)
developed recurring NEC and 4 patients
(36% of NEC patients) were re-admitted for
NEC development following initial discharge
(Tables 3 & 4). Variables associated with
NEC included low gestational age (34.3
weeks vs 35.8 weeks, P=0.016) and low
birth weight (P=0.003). Patients born prior
to 37 weeks gestation had a 4.8 times greater
risk of developing NEC than those born at
term. Rates of IUGR were not statistically
different between NEC and non-NEC
patients. The method of delivery (cesarean vs
vaginal), use of a silo, and form of nutrition
were not significantly associated with NEC
development. NEC developed on a median
of 65 days of life. Infants who developed

NEC stayed a median of 69 days longer than
patients who did not develop NEC (104 days
vs 35 days, P=0.014) (Tables 3 & 4).

Discussion
The incidence of gastroschisis is roughly 1
in 4,000 live births and appears to increase
with a 6% rise every two years for reasons
unknown.1,2,17-21 Worldwide, the survival
rate of infants born with gastroschisis has
also improved greatly.22,23 One of the known
complications of gastroschisis is necrotizing
enterocolitis. Although numerous reports of
gastroschisis have identified the rate of NEC
in gastroschisis, the last series to discuss this
complication in detail was published over
twenty years ago.1-2,4-6,9,11-16,24. From our series
of patients with gastroschisis, we reviewed
our experience and the recent literature to
update what is known about gastroschisis and
NEC.
NEC is primarily a disease of very low birth
weight, pre-term infants, affecting 10% of
infants born weighing less than 1500 grams
and resulting in high rates of morbidity and
mortality in neonatal intensive care units.12,25
Traditional NEC occurs by the second or third
week of life.26-28 NEC in gastroschisis presents
less traditionally. Gastroschisis patients

Gastroschisis patients who developed necrotizing enterocolitis were compared to gastroschisis
patients who did not develop necrotizing enterocolitis and data were compared using the MannWhitney test for continuous data and the Fisher’s Exact test for categorical data.
NEC Group n=11

Non-NEC Group n=207

Male

8 (73%)

112 (54%)

Female

3 (27%)

95 (46%)

Sex

Gestational age

0.352

35.8 weeks

0.016

1955 ± 299.0g
(1451 to 2435g)

2479 ± 422.2g
(1120 to 4200)

0.003

4 (36%)

36 (17.4%)

0.121

7 (64%)

138 (67%)

Vaginal Delivery

4 (36%)

69 (33%)

36% Yes

46% Yes

Delivery Method
Cesarean Section

1.000

N=218

Mean ±SD or number (%)
or range

Spontaneous Labor

Sex

55% Male
45% Female

Yes

1 (9%)

70 (34%)

Gestational age

35.69± 2.00 weeks
Range: 28-40weeks
32.6%
46%

No

10 (91%)

137 (66%)

Carried to term
Spontaneous labor
Birth weight

2455.0 ± 531.8g
Range: 1120-4200g

IUGR Rate

18.4% IUGR

Type of delivery

67% Cesarean
33% Vaginal
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P

34.3 ± 2.00 weeks

IUGR

Demographics of the total patient population
identify an average population of late pre-term
infants with a higher-than-normal rate of IUGR.

Among our NEC patients, only one (9%)
required surgical intervention. Our high
rate of successful conservative management
is unique in comparison to the general
neonatal NEC population, which typically
requires much higher rates of surgical
intervention.26-28 Fullerton et al observed a
24% (49 of 204) rate of surgical intervention
among gastroschisis patients with NEC12.
Fullerton et al identified a higher mortality
rate among surgical NEC patients compared
to those conservatively managed (12.2% vs
3.9%). These findings suggest a different, less
severe clinical course of NEC in gastroschisis
compared to NEC among very low birth
weight neonates. Fullerton et al suggested
this fact supports the view that NEC is an
“umbrella diagnosis” representing variant
underlying pathologies, stating prevention
and treatment must be tailored on a patientto-patient basis. Our study also experienced
only one mortality, unlike the high mortality

Table 3.

Birth weight

Table 2.

were diagnosed with NEC much later, with
a median day of diagnosis of 65 days of life.
Additionally, patients that developed NEC
generally weighed more than 1500 grams.
Necrotizing enterocolitis is typically treated
with gut rest, antibiotics, and, if needed,
surgery. Similar methods of treatment were
seen in our NEC patients.

0.758

Carried to term

0.108

Silo

0.228

Yes

7 (64%)

91 (44%)

No

4 (36%)

116 (56%)

5.9 ± 2.0 days
(2-8 days)

7.3 ± 3.1 days
(3-15d)

0.130

Mean Length
Range
Ventilator Days

2 (Q1, Q3= 2, 6)

2 (Q1, Q3= 1, 6)

0.544

Length of Stay

104 days (Q1, Q3= 56, 114)

35 days (Q1, Q3= 26, 56)

0.014
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Table 4.

Data on demographics and management of each patient who later developed necrotizing enterocolitis area included below.
Demographics
EGA
(weeks)

1

35

Birth
Weight
(g)

2160

Silo?

Yes

DOL
Diagnosed
(days)

94

Diagnosis and Treatment
Post
Closure
Day

88

How diagnosed

Bell’s
Stage

Antibiotics
Prescribed

Length
Antibiotics
Prescribed

80

Bloody stool
Pneumatosis
Temp. instability
Bradycardia
Dilated bowel loops

II a

Ampicillin,
Gentamicin,
Flagyl

8d

II a

Ampicillin,
Gentamicin,
Clendamycin

8d

Zosyn,
Gentamicin
Gentamicin,
Zosyn, Flagyl

LOS
(days)

2

32

1780

Yes

63

58

54

Pneumatosis
Distended bowel
Portal Air
Bloody stool
Abdominal distension

3

36

1724

Yes

54 & 75

47 & 68

114

Pneumatosis
Distended bowel
Portal Air
Ascites

III a

10d
10 d

4

37

2435

No

40

40

114

Abdominal distension
Portal venous gas
Fluid collection

III a

Vancomycin,
Gentamicin,
Zosyn

14d, 11d,
14d

5

36

2160

Yes

69 & 87

61 & 79

145

Pneumatosis
Bloody stool
Distended Bowel

II a

Zosyn
Zosyn,
Gentamicin,
Flagyl

7d
7d, 7d,
7+10 d

6

35

2255

No

73

73

25

Pneumatosis
Bloody stool
Intestinal ischemia

II a

Ampicillin,
Gentamicin,
Flagyl

14d

7

31

1451

Yes

15

13

199

Pneumatosis
Temp. instability
Loose stool
Lethargy

II b

Gentamicin,
Zosyn,
Vancomycin

21d, 3d, 9d

35, 55,
& 69

104

Pneumatosis
Temp. instability
Lethargy
Abdominal distension
Bilious emesis

II a

Zosyn
Vancomycin,
Zosyn

11d
7d

8

34

1990

Yes

42, 62,
& 76

9

36

2390

Yes

65 & 79

59 & 73

107

Feeding intolerance
Pneumatosis
Bloody stool

II a

Zosyn

10d, 7d

10

31

1700

No

52 & 76

52 & 76

36

Pneumatosis
Abdominal distension
Hematochezia

II a

Flagyl
Zosyn

7d
10d

11

34

1900

No

41

41

58

Pneumatosis
Temp. instability
Lethargy

II a

Zosyn
Vancomycin

7d

Mean

34

1990

62.5

58.1

89.8

rate seen in pre-term infants with NEC and
gastroschisis in prior studies.8
The last study to explore the association
of NEC and gastroschisis in detail was
Oldham’s study, published over 20 years
ago.4 Compared to his study, we experienced
a relatively low rate of NEC (18.5% vs 5%,
10/54 vs 11/218, respectively). An additional
13 patients in the former study had soft signs
of NEC, making the difference even greater.
Mortality in Oldham’s series was 20% overall
compared to the single death in our series.
These differences are likely due to advances
in perinatal, neonatal, and surgical care of this
17 Original Reports

complicated patient population. Further, our
current series carefully reviewed each NEC
case and assigned a Bell’s stage to ensure the
accuracy of diagnosis. Our rate of NEC in
this study was comparable to that rate found
in several more recent studies, ranging from
0-15%5-16 (Table 5).
Patients in Oldham’s study were diagnosed
with NEC on an average of 52 days of life,
comparable to our study (62.5 days, median
65 days). Both studies documented that
patients were readmitted due to development
of NEC (Oldham: 3/10, Current Study: 4/11).
Fifty-four percent (29 of 54) of patients

Surgery

Yes

in Oldham’s study vs. 55% (120/218) in
our study underwent primary closures of
their abdominal wall defect. Both reported
recurring NEC (Oldham: 38%, Current Study:
45%).4
Lao et al looked at 2490 gastroschisis patients,
with a NEC rate of 5%, which is comparable
to our experience (5%).4 The median length of
stay in Lao’s study was 35 days, as opposed
to our 104 day median length of stay. Forty
percent of NEC patients were born prior to
37 weeks gestation in Lao’s study, while the
number climbed to 91% in our study. Lao
et al identified potential modifiable factors
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impacting mortality to include large bowel
resection and the presence of bacterial sepsis,
both factors associated with NEC. The clinical
impact of NEC is consistent in both studies,
emphasizing the importance of identifying
modifiable factors to reduce the incidence of
NEC.
Older reports of gastroschisis have suggested
early delivery may be associated with better
outcomes.29-31 This remains controversial.
More recent studies show worse outcomes
with early delivery, including an increased
risk of infectious complications32 and poorer
long-term neurodevelopmental outcomes.33
Maramreddy et al found gastroschisis patients
delivered prior to 37 weeks gestation had
a 14 times greater risk of morbidities than
patients carried to term.6 Soares et al also did
not support pre-term delivery of fetuses with
gastroschisis, finding no benefit to achieving
full feeds faster.1 Huang et al found that
gastroschisis pregnancies carried to term led
to earlier defect closures, and shorter times
to full feeds, suggesting that the benefits
of early delivery cannot be substantiated.34
Gorra et al found that pre-term gastroschisis
patients experienced poorer developmental
outcomes.33 Pre-term, low birth weight infants
have been identified as being at increased
risk of infection.32 Patients who developed
NEC were on average 1.5 weeks younger at
birth and weighed 484 grams less. Infants not
carried to term were found to be 4.8 times
more likely to develop NEC than infants
carried to term. This raises concern about an
increased risk of NEC with scheduled preterm delivery of patients with gastroschisis.
Prior publications have identified the
protective nature of human breast milk
against late onset sepsis, NEC, and death.9,35-36
The etiology of this may be associated with
more swift weight gain and reduced feeding
intolerance associated with breastfed infants.
Unlike these studies, our study found no
statistically significant difference in the rate
of NEC due to form of nutrition. The practice
of initiating trophic feeds within the first 72
hours may also promote digestive tolerance,
allowing faster volume increases and helps the
neonate achieve full feeds earlier.37
The gastroschisis patients whom develop
NEC tend to have a much more complicated
medical course, resulting in a longer length
of stay on average. NEC can also occur after
discharge home, requiring readmission of 4 of
our patients. Because NEC presents itself very
differently in the gastroschisis population as
compared to the general neonatal population,
it is vital for neonatologists, surgeons, and
general pediatricians to remain vigilant to
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Table 5.

Literature review of relevant studies reviewing this topic are summarized below.
Author

Date

Patients

NEC
Patients

Rate of
NEC

Conclusion

Oldham

1988

54

10

18.5%

High incidence of NEC: 30% readmitted for NEC
(3 of 10)

Jayanthi

1998

54

8

15%

Unpasteurized, expressed breast milk may
protect from NEC

Snyder

1999

185

8

4%

Increased mortality seen in NEC patients (3 of 8)

Eggick

2006

66

6

9%

No difference seen between NEC and No-NEC
patients in regards to birth weight or gestational
age

Charlesworth

2007

110

7

6.36%

NEC was more frequent in pre-term (P=0.13)
and infants larger than 2kg (P=0.15)

Maramreddy

2009

36

3

8.3%

No NEC found in term infants

Lao

2010

2490

127

5.1%

5% NEC according to PHIS database

Kassa

2011

79

0

0%

No NEC observed

Overcash

2014

191

2

1%

Early gestational age was only variable to predict
adverse outcomes

De Buys

2015

68

5

7.4%

Database mortality rate of 12%

Fullerton

2017

4420

204

4.6%

3.9% death rate among NEC patients
49 surgical NEC cases (12.2% mortality among
surgical cases)

Gupta

2017

682

26

3.8%

NEC risk associated with outborn status,
admission after 2009, and CLABSI

Current Study

2017

218

9

4.1%

NEC more common in small, pre-term infants:
44% readmitted for NEC (4 of 11)

the possibility of acute illness outside of the
setting of a patient’s initial hospitalization for
gastroschisis repair. For those gastroschisis
patients who do experience NEC as a
complication, conservative management is
more frequently successful as compared to
NEC in the general neonatal population
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